Products

SanguiBioTech GmbH has developed or licensed a number of products and technologies which are now ready for market entry or approaching regulatory approval. They are in line with the basic Sangui approach to strive for the biological regeneration of cells through compensatory supply of vital substrates to the human body.

Aging and diseases of the skin can be traced back to a lack of oxygen. Sangui has developed an innovative micro-emulsion which penetrates the stratum corneum and thus enables an increased afflux of oxygen from the air. Dermatological tests have shown excellent and - notably - sustainable moisturizing effects. It is part of our PURE MO2ISTURE anti-aging skin care program. The company continues to look for additional applications of the basic micro-emulsion technology.

Chronic wounds are among the worst skin deficiencies, causing constant pain and embarrassment. Based on Sangui's unmatched expertise in the field of artificial oxygen carriers, the company has developed HEMO2SPRAY a haemoglobin spray which apparently has a significant positive effect on wound healing according to initial therapeutic experiments with numerous patients. In most cases, wounds which had been considered unhealable by dermatologists were healed within days or weeks, the skin returning to normal condition.

Since October, 2006, Sangui cooperates with E.R.C. Nano Med S.A. de C.V. of Monterrey, Mexico. The company specializes in innovative medical products and intends to use Sanguis HEMO2SPRAY woundspray as key therapeutical in an attempt to improve wound healing throughout Mexico. E.R.C have established a wholly-owned subsidiary under the name of Sangui Latino America. A first wound ambulance was established in the beginning of 2007, where numerous treatments have been and are being carried out. These treatments aiming at regulatory clearance of the woundspray product in Mexico and other Latin American countries have proven to be very successful so far. A German translation of a comprehensive presentation showing successful wound healings and presenting background information is now available on our website.
[Download PDF-File of presentation (1.8 MB)] Please contact us for a Spanish language presentation. An extended English version is being prepared.

While oxygen supply apparently promotes the healing of chronic wounds, normal wounds need substrate supplies and a renewed cell matrix to heal fast and regenerate to an intact skin structure. This process is considerably facilitated by our innovative CHITOSKIN wound pads, which are now close to regulatory clearance. Remarkably enough and due to its specific molecular structure, Chitoskin demonstrates in all phases of wound healing not only the desired physical characteristics but also most favorable biological effects, caused by the chemical similarity with the natural matrix. At present there is no product available which is able to compete with the manifold favorable properties Chitoskin shows in each phase of wound healing.